Business
Press Release Mar 05 2024
Strides Pharma Science Limited has informed the Exchange regarding a press release dated March 05, 2024, titled "Strides receives USFDA approval for Gabapentin Tablets USP, 600 mg and 800 mg".
About this update from Strides Pharma Science Ltd
[{"type":"text","content":" Strides Pharma Science Limited has informed the Exchange regarding a press release dated March 05, 2024, titled \"Strides receives USFDA approval for Gabapentin Tablets USP, 600 mg and 800 mg\". View Attachment","length":340,"tagName":"div"}]